Green Thumb Industries (GTBIF) Net Cash Flow Growth (3y) (2022 - 2026)
Green Thumb Industries (GTBIF) Net Cash Flow Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.06 Bn | 87.19 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn | 32.03% |
| 3 | Zoetis | 32.51 Bn | 30.57 Bn | 1.62 Bn | 28.99% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | 37.89% |
| 5 | United Therapeutics | 23.18 Bn | 21.03 Bn | 648.10 Mn | -49.94% |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn | 37.74% |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn | -41.05% |
| 9 | Elanco Animal Health | 12.63 Bn | 12.21 Bn | 785.00 Mn | -62.71% |
| 10 | Green Thumb Industries | 1.64 Bn | 1.29 Bn | 143.65 Mn | 99.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 99.40% |
| Dec 31, 2025 | 17.91% |
| Sep 30, 2025 | 209.08% |
| Jun 30, 2025 | -4.78% |
| Mar 31, 2025 | 39.18% |
| Dec 31, 2024 | 67.20% |
| Sep 30, 2024 | 32.57% |
| Jun 30, 2024 | -32.64% |
| Mar 31, 2024 | -31.30% |
| Dec 31, 2023 | 63.55% |
| Sep 30, 2023 | -35.93% |
| Jun 30, 2023 | -73.05% |
| Mar 31, 2023 | -32.38% |
| Dec 31, 2022 | 52.75% |
| Sep 30, 2022 | 26.59% |
| Jun 30, 2022 | -52.79% |
| Mar 31, 2022 | -24.58% |